Sahajanand Medical Technologies Limited IPO

Sahajanand Med Tech has registered for an initial public offering (IPO) in the amount of Rs.1,500 crore with SEBI. A fresh issuance of Rs.410.33 crore and an offer for the sale of equity shares worth Rs.1,089.67 crore are included in the IPO. Dhiraj Kumar S Vasoya is selling Rs.100 crore worth of shares, Shree Hari Trust is selling Rs.33.75 crore worth of shares, and Samara Capital Markets Holding is selling Rs.635.56 crore worth of shares, and NHPEA Sparkle Holding BV is selling Rs.320.36 crore worth of shares.
They are also mulling an Rs.185 crore pre-IPO placement. Axis Capital Ltd, BofA Securities India Ltd, Edelweiss Financial Services, and UBS Securities India Pvt Ltd are the book-running lead managers for this issuance.

Opening Date

To be announced

Closing Date

To be announced

Price Band

To be announced

Issue Size

To be announced

Face Value

To be announced

Market Lot

To be announced

Opening Date

To be announced

Closing Date

To be announced

Price Band

To be announced

Issue Size

To be announced

Face Value

To be announced

Market Lot

To be announced

Listing at NSE, BSE

Sahajanand Medical Technologies Ltd. IPO Important Dates

IPO Open Date To be announced
IPO Close Date To be announced
Allotment Date To be announced
Initiation Of Refunds To be announced
Credit Of Shares To
Demat Account
To be announced
IPO Listing Date To be announced
UPI Mandate Expiry Date To be announced

View all upcoming IPOs

About Sahajanand Medical Technologies Limited

Sahajanand Medical Tech was founded in 2001 and is a major medical device firm that specialises in the research, development, production, and marketing of vascular devices all over the world. In India, they maintained a 31 per cent market share in the drug-eluting stent market in FY21. As of March 31, 2021, Sahajanand was among the top five corporations in market share in nations such as Germany, the Netherlands, Poland, and Italy. They sell and distribute their products in 69 countries throughout the world. Interventional cardiology, structural heart treatment, and peripheral intervention are all areas where their products are employed. Surat, Galway, Ireland, and Nonthaburi, Thailand are the locations of their three research and development centres. Sahajanand Medical Technologies has received 67 patents worldwide, with 17 more patents in the works and four design registrations in India.

The firm has 946 full-time workers, 410 contract employees, and 24 consultants as of March 31, 2021. Their sales force consists of 131 salespeople scattered over 37 locations. Sterling AddLife India Pvt Ltd, Fortis Hospitals, Max Hospitals, and Paras Hospitals are among Sahajanand Med Tech's most important clients.

Sahajanand Medical Technologies Limited IPO Objectives

Here are a few quick reasons why Sahajanand Medical Technologies Limited going public:

- Repayment/ prepayment of certain indebtedness availed by the Company and our Subsidiaries.
- Funding the working capital requirements of its indirect foreign subsidiary, Vascular Innovations Co. Ltd. (“Vascular Innovations”).
- General corporate purposes.

Why should you invest in the Sahajanand Medical Technologies Limited IPO?

  • They are a leading medical devices company that researches, designs, develops, manufactures and markets vascular devices globally.
  • As of March 31, 2021, they have been granted 67 patents globally with a pipeline of additional 17 patents and four design registrations in India.

Financial Highlights

Particulars FY21 FY20 FY19
Revenue 588.52 479.9 326.11
PAT (72.38) 25.43 25.43
EPS (8.13) 2.69 3.67
Total Assets 861.95 631.78 520.36
Total Borrowings 325.10 87.21 69.64
Equity Share Capital 8.89 8.89 8.89

How to apply for Sahajanand Medical Technologies Limited IPO

There are two simple processes through which any new investors can start their trading journey. One is through UPI, and the other is with the help of a Demat account. The processes are discussed below:

UPI

  • Step 1: Open your bank account and link a UPI ID with it
  • Step 2: Once your Demat account is all set, link your UPI ID with it
  • Step 3: Subscribe to Sahajanand Medical Technologies Limited IPO and accept the payment request on your UPI ID

Demat Account

Sahajanand Medical Technologies Limited IPO Noteworthy Highlights:

  • Company is Market leading position in interventional cardiology in India, leveraging on industry growth drivers.
  • Company's interventional cardiology suite of products, Supraflex, against that of a global leading stent manufacturer demonstrated that Supraflex’s clinical performance is at par on safety factors and numerically superior to others.
  • In Fiscals 2019, 2020 and 2021, our revenue from operations was ₹3,261.15 million, ₹4,799.09 million and ₹5,885.21 million, respectively. Our revenue from operations has grown at a CAGR of 21.74% from Fiscal 2019 to Fiscal 2021.

The Brand’s Pros & Cons:

Pros Cons
The firm competes in a market with high entry barriers, which means there is less competition, and they provide cutting-edge items. The company's market is heavily regulated, which may make obtaining the necessary approvals for various items more difficult.
In India, Sahajanand Med Tech is the market leader in interventional cardiology, with a market share of 31% in FY21. There may be instances when the firm is unable to carry out its business strategies, which will impede its growth.
In addition to direct operations in ten countries, the corporation has distributors in 59 more. Foreign currency rate changes will have a significant impact on the company's operations.

Competitive Analysis: Market Peers

Particulars (In USD Mn) Medtronic Boston Scientific Abbott Edwards Life Science
Revenue 30,117 9,913 34,608 4,386
EBITDA 8,236 1,723 8,618 1,431
EBITDA Margin 27.35% 17.38% 24.90% 32.63%
ROE 7.06 (0.56) 13.93 18.88
Net Income Margin 12% (0.83%) 12.86% 18.77%
Debt to Equity 53.29 62.73 60.67 15.19

Sahajanand Medical Technologies Limited IPO FAQs

What is Sahajanand Medical Technologies Limited's Initial Public Offering?

Sahajanand Medical Technologies Ltd has filed for an Rs. 1,500 crore IPO with SEBI which comprises a fresh issue of Rs. 410.33 crore and an offer for sale of OFS of Rs. 1,089.67 crore.

When will allotments for the Sahajanand Medical Technologies Limited IPO become available?

Sahajanand Medical Technologies Limited IPO will finalize the allotment by <>.

What will the IPO lot size for Sahajanand Medical Technologies Limited be?

Each Sahajanand Medical Technologies Limited IPO lot has <> shares.

When will Sahajanand Medical Technologies Limited IPO be available to buy?

The IPO of Sahajanand Medical Technologies Limited will be open for subscription from <>.

What is Sahajanand Medical Technologies Limited’s smallest lot size available to retail investors?

The minimum market lot size for the Sahajanand Medical Technologies Limited IPO is <> shares.

Which exchanges will Sahajanand Medical Technologies Limited list on?

Sahajanand Medical Technologies Limited shares will be listed on both BSE as well as the National Stock Exchange (NSE).

What is the IPO size of Sahajanand Medical Technologies Limited?

The IPO size of Sahajanand Medical Technologies Limited is Rs 410.33 crore.

How to check the allotment status of Sahajanand Medical Technologies Limited IPO on the AngelOne App?

The easiest ways to check your IPO allotment status on the AngelOne app are below:
  • Step 1: Login & Look for Investment Opportunities via Angelone App.
  • Step 2: Choose IPOs & FPOs.
  • Step 3: Click Order Book.

How will I get my Sahajanand Medical Technologies Limited stock?

Following allotment, the Sahajanand Medical Technologies Limited shares will be credited to the Demat account.

Can I use one PAN to submit multiple applications for the public issue of Sahajanand Medical Technologies Limited?

No, you cannot use the same PAN to make multiple applications for this Sahajanand Medical Technologies Limited IPO or any other public offering.

Is it necessary to give immediate approval to a UPI mandate request?

Yes, immediately approving a UPI mandate request is preferable. Accepting it as soon as you receive it is much better.

Who owns Sahajanand Medical Technologies Limited?

Mr Dhirajlal Kotadia Govind Singh is the current owner of Sahajanand Medical Technologies Limited.

What are the expected listing gains for the Sahajanand Medical Technologies Limited IPO?

It is difficult to anticipate the listing gains of each IPO, however, there are a few factors that have a significant impact:
  1. Market movement on the day of the listing.
  2. Sahajanand Medical Technologies Limited stock market supply and demand from investors and dealers.
  3. The interest of HNI investors in particular.

Enjoy Zero Brokerage on
Stock Investments

Get the link to download the app

Enjoy Lifetime Free Delivery Trade

Download the app now

Or Scan below QR Code

to download App